Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generation of precursor T cells from G-CSF-mobilized CD34+ stem cells from healthy volunteers
NL-OMON36844Recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Apr 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of filgrastim in hematopoietic malignancies and leukemia, sponsored by Maastricht University Medical Center+. Primary endpoints: Feasibility of generating precursor T cells in a GMP-compliant in vitro system and Primary study parameters not formally defined. Started Apr 2013; status: recruiting.
02
Drugs
filgrastim
03
Conditions
hematopoietic malignanciesleukemia
Beyond the preview
Go deeper on NL-OMON36844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36844.